Asuragen Publications


JP Cogswell, J Ward, IA Taylor, M Waters, Y Shi, B Cannon, K Kelnar, J Kemppainen, D Brown, C Chen, RK Prinjha, JC Richardson, AM Saunders, AD Roses, and CA Richards, Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis, May 2008; 14(1): 27-41.


Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008 May;14(5):844-52. Epub 2008 Mar 28.


Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, Szafranska AE. Evaluation and validation of total RNA extraction methods for MicroRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2008 May;10(3):203-11. Epub 2008 Apr 10.

Pappas TC, Bader AG, Andruss BF, Brown D, Ford LP: Applying small RNA molecules to the directed treatment of human diseases: realizing the potential. Expert Opin Ther Targets 2008, 12:115-127.

Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, et al.: The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells. Cancer Res 2007, 67:7713-7722.

Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D: Genome-Scale MicroRNA and Small Interfering RNA Screens Identify Small RNA Modulators of TRAIL-Induced Apoptosis Pathway. Cancer Res 2007, 67:10782-10788.

Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452.

Brown JT, Lahey C, Laosinchai-Wolf W, Hadd AG: Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P). BMC Med Genet 2006, 7:69.

Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Jr., Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, et al.: The colorectal microRNAome. Proc Natl Acad Sci U S A 2006, 103:3687-3692.

Davison TS, Johnson CD, Andruss BF: Analyzing Micro-RNA Expression Using Microarrays. Methods Enzymol 2006, 411:14-34.

Madabusi LV, Latham GJ, Andruss BF: RNA extraction for arrays. Methods Enzymol 2006, 411:1-14.

Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, et al.: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006, 24:1151-1161.

Shippy R, Fulmer-Smentek S, Jensen RV, Jones WD, Wolber PK, Johnson CD, Pine PS, Boysen C, Guo X, Chudin E, et al.: Using RNA sample titrations to assess microarray platform performance and normalization techniques. Nat Biotech 2006, 24:1123-1131.

Cheng AM, Byrom MW, Shelton J, Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.

Hadd AG, Brown JT, Andruss BF, Ye F, WalkerPeach CR: Adoption of array technologies into the clinical laboratory. Expert Rev Mol Diagn 2005, 5:409-420.

Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ: RAS Is Regulated by the let-7 MicroRNA Family. Cell 2005, 120:635-647.

Ovcharenko D, Jarvis R, Hunicke-Smith S, Kelnar K, Brown D: High-throughput RNAi screening in vitro: From cell lines to primary cells. RNA 2005, 11:985-993.

Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R, Brown D, Labourier E: An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005, 11:1461-1470.

Hadd AG, Laosinchai-Wolf W, Novak CR, Badgett MR, Isgur LA, Goldrick M, Walkerpeach CR: Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms. J Mol Diagn 2004, 6:348-355.

Walkerpeach CR, Pasloske BL: DNA bacteriophage as controls for clinical viral testing. Clin Chem 2004, 50:1970-1971.

Brown D, Pasloske BL: Ribonuclease-resistant RNA controls and standards. Methods Enzymol 2001, 341:648-654.

WalkerPeach CR, Winkler M, DuBois DB, Pasloske BL: Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin Chem 1999, 45:2079-2085.

Pasloske BL, Walkerpeach CR, Obermoeller RD, Winkler M, DuBois DB: Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J Clin Microbiol 1998, 36:3590-3594.


Last updated June 5, 2008